1. Home
  2. INSE vs VRCA Comparison

INSE vs VRCA Comparison

Compare INSE & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspired Entertainment Inc.

INSE

Inspired Entertainment Inc.

N/A

Current Price

$4.50

Market Cap

83.6M

Sector

Technology

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

N/A

Current Price

$3.80

Market Cap

88.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INSE
VRCA
Founded
2002
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.6M
88.0M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
INSE
VRCA
Price
$4.50
$3.80
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$6.85
★ $13.83
AVG Volume (30 Days)
★ 516.7K
55.8K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $199,800,000.00
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.15
$60.79
P/E Ratio
★ N/A
N/A
Revenue Growth
30.25
★ 370.22
52 Week Low
$3.10
$3.08
52 Week High
$9.95
$9.82

Technical Indicators

Market Signals
Indicator
INSE
VRCA
Relative Strength Index (RSI) 64.60 53.62
Support Level $3.20 $3.30
Resistance Level $8.42 $4.17
Average True Range (ATR) 0.31 0.28
MACD 0.17 0.08
Stochastic Oscillator 88.44 89.94

Price Performance

Historical Comparison
INSE
VRCA

About INSE Inspired Entertainment Inc.

Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: